Literature DB >> 1001207

[Prajmalium bitartrat-induced liver damage (author's transl)].

H Lindner, D Weber, G Klöppel.   

Abstract

Liver damage was found in five patients (three men, two women) who were receiving prajmalium bitartrate. The cause was proven by re-exposure which was positive in all instances. The illness tended to start with acute fever and severe upper abdominal pains. When the drug was continued in one case, laparotomy was performed for suspected obstructive jaundice. Another patient had been admitted for operation because of jaundice. On re-exposure the most striking feature was a definite rise in glutamate-dehydrogenase. Prajmalium bitartrate is thus no better tolerated by the liver than ajmalin: both clinically, biochemically and morphologically the two drugs affect the liver similarly.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1001207     DOI: 10.1055/s-0028-1104362

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

Review 1.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

2.  Cholestatic jaundice: an immune response to prajmalium bitartrate.

Authors:  H H Rotmensch; M Liron; I Yust; A Klejman; E Livni; T Moalem; A Gefel
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401

3.  Prajmaliumbitartrate-associated liver damage. Report on seven further cases with follow-up for two to five years.

Authors:  G Börsch; G Schmidt; G Hopmann; T Surmann; G Sabin; D Ricken
Journal:  Klin Wochenschr       Date:  1984-10-15

4.  [Intrahepatic cholestasis and aplastic anemia following administration of prajmaline].

Authors:  R Lenzen; H Gottesbüren; F Borchard; M Wienbeck; G Strohmeyer
Journal:  Klin Wochenschr       Date:  1988-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.